Comerica Bank’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$87.6K Buy
2,213
+1,212
+121% +$44.4K ﹤0.01% 2662
2025
Q3
$35.3K Sell
1,001
-58
-5% -$2K ﹤0.01% 2934
2025
Q2
$34.7K Buy
1,059
+320
+43% +$10.4K ﹤0.01% 2907
2025
Q1
$23.8K Buy
739
+74
+11% +$2.75K ﹤0.01% 2985
2024
Q4
$20.3K Buy
665
+181
+37% +$5.82K ﹤0.01% 3025
2024
Q3
$13.6K Sell
484
-1,182
-71% -$29.1K ﹤0.01% 3121
2024
Q2
$37.9K Sell
1,666
-856
-34% -$19.8K ﹤0.01% 2831
2024
Q1
$76.7K Buy
2,522
+1,043
+71% +$34.9K ﹤0.01% 2627
2023
Q4
$52.8K Sell
1,479
-993
-40% -$36.9K ﹤0.01% 2705
2023
Q3
$108K Buy
+2,472
New +$121K ﹤0.01% 2445

Other funds holding ATRC

Comerica Bank's ATRC Position: Q4 2025 in Review

Comerica Bank increased its AtriCure (ATRC) stake by 121% in Q4 2025, buying an estimated $44.4K and bringing the position to 2,213 shares worth $87.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2662.

Comerica Bank first reported a position in ATRC in Q3 2023 and has held it in 10 quarters since. The position peaked at $108K in Q3 2023. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2025.

  • Comerica Bank held 2,213 shares of AtriCure worth $87.6K as of Q4 2025.
  • Comerica Bank bought 1,212 AtriCure shares in Q4 2025, an estimated $44.4K.
  • AtriCure made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2662 holding.
  • Comerica Bank first reported a position in AtriCure in Q3 2023 and has held it in 10 quarters since.
  • Comerica Bank's AtriCure position peaked at $108K in Q3 2023.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.